March 8th, 2017
This webinar will present an overview of the challenges to drug development from the standpoint of the need for new sources of evidence. It will also include a presentation on what the 'RWE Navigator' is, and what it does with a live demonstration of the web tool.
DIA Bioventure Day 28 March 2017, Crown Plaza Glasgow, UK Speakers Click here to see all the speakers and bios In collaboration with
DIA Bioventure Day 28 March 2017, Crown Plaza Glasgow, UK Where is Innovation in Health Care heading? By Holger Adelmann, DIA EMEA Is Europe geared up to provide an infrastructure to nurture Biotechs? The European Biotechnology Enterprises (EBE) has done a very critical assessment! Is the Pharma sector still [...]
March 28th, 2017
DIA is excited to convene its 1st BioVenture Day, in a unique format with participation of a very broad set of senior Health Care stakeholders.You will be able to explore whether the current BioVenture paradigm is delivering return for patients, investors, and the Health Care system.
IMI 1 GetReal closing meeting: ‘Delivering tools for real-world evidence development’ 24 November, 2016, Brussels Royal Flemish Academy of Belgium for Science and the Arts Venue Royal Flemish Academy of Belgium for Science and the Arts Hertogstraat 1 Rue Ducale 1000 Brussels Supported [...]
24th November 2016
IMI 1 GetReal closing meeting: ‘Delivering tools for real-world evidence development’
Supported by:
October 6, 2016
WP 3 has two main goals. Identify operational challenges when implementing RWE research to investigate the effectiveness of medicines, earlier in the medicine development process. Second, to estimate the impact of these challenges on the ability to generate the RWE originally aimed for and the feasibility of the research and provide practical solutions to help address them. This webinar will update you on these goals.